Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Alzheimer'S & Dementia (New York, N. Y.)
|
February 15, 2024
The functional role of the pulvinar in discriminating between objective and subjective cognitive impairment in major depressive disorder
Burak Yulug, Sevilay Ayyildiz, Dila Sayman, et al.
Translational Psychiatry
|
September 1, 2025
Subjective cognitive decline in major depressive patients is associated with altered entropy and connectivity changes of temporal and insular region
Burak Yulug, Ali Yalcinkaya, Shair Shah Safa, et al.
Neuroimage
|
December 15, 2024
Hippocampal connectivity dynamics and volumetric alterations predict cognitive status in migraine: A resting-state fMRI study
Seyda Cankaya, Behcet Ayyildiz, Dila Sayman, et al.
Brain and Behavior
|
October 21, 2025
The Role of Willpower in Major Depressive Disorder: An fMRI Study
Burak Yulug, Burak Uygur, Dila Sayman, et al.
Journal of Medical Virology
|
September 19, 2023
Infection with COVID-19 is no longer a public emergency: But what about degenerative dementia?
Burak Yulug, Behçet Ayyıldız, Sevilay Ayyıldız, et al.
Alzheimer'S Research & Therapy
|
October 2, 2024
Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease
Lingqi Meng, Han Jin, Burak Yulug, et al.
Iscience
|
November 24, 2025
Cognitive impairment in tension-type headache is associated with altered hippocampal functional connectivity
Burak Yulug, Ali Yalcınkaya, Shair Shah Safa, et al.
Neurobiology of Disease
|
May 2, 2026
Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity
Han Jin, Lingqi Meng, Burak Yulug, et al.
Life Sciences
|
December 29, 2022
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
Hasan Turkez, Ozlem Altay, Serkan Yildirim, et al.
Translational Neurodegeneration
|
January 26, 2023
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yulug, Ozlem Altay, Xiangyu Li, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Alzheimer'S & Dementia (New York, N. Y.)
|
February 15, 2024
The functional role of the pulvinar in discriminating between objective and subjective cognitive impairment in major depressive disorder
Burak Yulug, Sevilay Ayyildiz, Dila Sayman, et al.
Translational Psychiatry
|
September 1, 2025
Subjective cognitive decline in major depressive patients is associated with altered entropy and connectivity changes of temporal and insular region
Burak Yulug, Ali Yalcinkaya, Shair Shah Safa, et al.
Neuroimage
|
December 15, 2024
Hippocampal connectivity dynamics and volumetric alterations predict cognitive status in migraine: A resting-state fMRI study
Seyda Cankaya, Behcet Ayyildiz, Dila Sayman, et al.
Brain and Behavior
|
October 21, 2025
The Role of Willpower in Major Depressive Disorder: An fMRI Study
Burak Yulug, Burak Uygur, Dila Sayman, et al.
Journal of Medical Virology
|
September 19, 2023
Infection with COVID-19 is no longer a public emergency: But what about degenerative dementia?
Burak Yulug, Behçet Ayyıldız, Sevilay Ayyıldız, et al.
Alzheimer'S Research & Therapy
|
October 2, 2024
Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease
Lingqi Meng, Han Jin, Burak Yulug, et al.
Iscience
|
November 24, 2025
Cognitive impairment in tension-type headache is associated with altered hippocampal functional connectivity
Burak Yulug, Ali Yalcınkaya, Shair Shah Safa, et al.
Neurobiology of Disease
|
May 2, 2026
Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity
Han Jin, Lingqi Meng, Burak Yulug, et al.
Life Sciences
|
December 29, 2022
Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases
Hasan Turkez, Ozlem Altay, Serkan Yildirim, et al.
Translational Neurodegeneration
|
January 26, 2023
Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial
Burak Yulug, Ozlem Altay, Xiangyu Li, et al.
Page
of 4